Showing 1 - 10 of 429
In our cost-effectiveness analysis of first-line injectable DMTs in Spain, we found IM IFNβ-1a to be more cost-effective than SC IFNβ-1a, IFNβ-1b or GA. Sensitivity analyses confirmed the robustness of these results. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014
Persistent link: https://www.econbiz.de/10010993865
Backcalculation is a technique that was originally developed for the study of HIV incidence. Here we introduce some variants of the estimation technique that allow for (i) correlation of the unobserved disease incidence counts, and (ii) the use of a smoothing step as part of the maximizing step...
Persistent link: https://www.econbiz.de/10005246581
The need for priority setting in health care systems has forced us to think more carefully about objectives and opportunity costs. If our objective is the maximisation of the health of the community, for this to be an effective guide to action we have to find some practical way of describing and...
Persistent link: https://www.econbiz.de/10005344425
Persistent link: https://www.econbiz.de/10010539279
Persistent link: https://www.econbiz.de/10009324591
Persistent link: https://www.econbiz.de/10009402185
Persistent link: https://www.econbiz.de/10009404150
Persistent link: https://www.econbiz.de/10009404198
Persistent link: https://www.econbiz.de/10009404207
Persistent link: https://www.econbiz.de/10009404227